Dr. Aswin Doekhie (EnsiliTech)

Overview

Dr. Aswin Doekhie is a prominent figure in the field of biotechnology, best known for his role as the Chief Technology Officer (CTO) and co-founder of EnsiliTech, a groundbreaking biotech startup revolutionizing the preservation and transportation of vaccines and biopharmaceuticals. With a deep understanding of biochemistry, physical chemistry, and microbiology, Dr. Doekhie has been instrumental in the development and commercialization of the "Ensilication" technology, which enables the stabilization of biological materials without the need for refrigeration. This innovation has the potential to significantly impact global healthcare by reducing vaccine wastage and improving access to life-saving medicines.

Recent Developments

August 2025: EnsiliTech successfully completed a £4.5 million seed funding round led by Eos Advisory, with additional investments from Calculus Capital and HERmesa. This funding aims to expand manufacturing capabilities, enhance key hires, and integrate Ensilication into pharmaceutical manufacturing [1].
March 2025: EnsiliTech received the Technology Award at the Bristol Life Awards 2025, recognizing its innovative approach to vaccine stability and global healthcare [2].
July 2024: Awarded the SPARKies Award for Most Innovative Use of Tech, highlighting its impact on biopharmaceutical storage and transportation [3].
2024: Secured a government contract to develop the world's first thermally stable mRNA vaccine, adding to its accolades for innovative use of technology [4].
December 2022: EnsiliTech finalized its first oversubscribed pre-seed investment round of £1.2 million, including an Innovate UK grant and private investment [5].

Personal Information

Attribute	Information
Full Name	Aswin Doekhie
Nationality	British
Occupation	Chief Technology Officer (CTO)
Known For	Co-founding EnsiliTech, Ensilication Technology
Education	PhD in Chemistry, University of Bath

Early Life and Education

Dr. Aswin Doekhie was born in the United Kingdom and developed an early interest in the sciences. He pursued his higher education in chemistry with a focus on applications in biopharmaceuticals and vaccine development. Dr. Doekhie earned his PhD from the University of Bath, where he specialized in physical chemistry, biochemistry, and microbiology, laying the groundwork for his future contributions to EnsiliTech.

During his academic career, Dr. Doekhie was involved in innovative research projects, including the use of silica-based stabilization processes. His passion for developing technologies that could improve global health outcomes was a driving force in his early career path. This passion crystallized during his doctoral studies, influencing his later work on the Ensilication method.

Career and Notable Achievements

Dr. Aswin Doekhie began his career with a focus on chemical stabilization techniques applicable to the biopharmaceutical industry. As the CTO of EnsiliTech, his professional journey includes:

Co-founding EnsiliTech: Dr. Doekhie's role in developing Ensilication technology, a platform that stabilizes biological materials at ambient temperatures without refrigeration.
Groundbreaking Publications: Authored and co-authored influential papers in the field of biopharmaceutical stabilization [6].
Industry Recognition: Under his leadership, EnsiliTech won several accolades, including the SPARKies Award for Most Innovative Use of Tech [3].
Strategic Partnerships: Played a crucial role in securing significant funding and government contracts for vaccine development [5].

Current Work and Impact

Currently, Dr. Aswin Doekhie continues to lead research and development at EnsiliTech, focusing on scaling up the Ensilication technology for widespread industrial application. His work significantly impacts the biopharmaceutical supply chain by reducing dependency on cold chain logistics, thereby enhancing the reach of vaccines to remote and underprivileged regions.

Dr. Doekhie's contributions are also pivotal in positioning EnsiliTech as a leader in sustainable healthcare solutions, aligned with global efforts to reduce the environmental impact of medical logistics.

Conclusion

Dr. Aswin Doekhie’s work at EnsiliTech has positioned him as a key innovator in the field of biotechnology. His contributions to the development of Ensilication technology are set to revolutionize the storage and distribution of vaccines and biologics. As EnsiliTech continues to expand its influence globally, Dr. Doekhie’s role will likely remain vital in advancing technological solutions that address some of the most pressing challenges in global health, ensuring equitable access to essential medicines.